197 related articles for article (PubMed ID: 29907571)
21. hERG 1b is critical for human cardiac repolarization.
Jones DK; Liu F; Vaidyanathan R; Eckhardt LL; Trudeau MC; Robertson GA
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18073-7. PubMed ID: 25453103
[TBL] [Abstract][Full Text] [Related]
22. Nonsense-Mediated mRNA Decay of hERG Mutations in Long QT Syndrome.
Gong Q; Zhou Z
Methods Mol Biol; 2018; 1684():37-49. PubMed ID: 29058182
[TBL] [Abstract][Full Text] [Related]
23. Stop codons and the +4 nucleotide may influence the efficiency of G418 in rescuing nonsense mutations of the HERG gene.
Yu H; Meng Y; Zhang S; Tian C; Wu F; Li N; Li Q; Jin Y; Pu J
Int J Mol Med; 2019 Dec; 44(6):2037-2046. PubMed ID: 31573043
[TBL] [Abstract][Full Text] [Related]
24. Serine mutation of a conserved threonine in the hERG K
Al-Moubarak E; Zhang Y; Dempsey CE; Zhang H; Harmer SC; Hancox JC
Biochem Biophys Res Commun; 2020 Jun; 526(4):1085-1091. PubMed ID: 32321643
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant.
Al-Moubarak E; Shiels HA; Zhang Y; Du C; Hanington O; Harmer SC; Dempsey CE; Hancox JC
Cell Mol Life Sci; 2021 Dec; 78(23):7899-7914. PubMed ID: 34727194
[TBL] [Abstract][Full Text] [Related]
26. Identification of a proton sensor that regulates conductance and open time of single hERG channels.
Wilson SL; Dempsey CE; Hancox JC; Marrion NV
Sci Rep; 2019 Dec; 9(1):19825. PubMed ID: 31882846
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Kv11.1 potassium channel C-terminal isoform expression by the RNA-binding proteins HuR and HuD.
Gong Q; Stump MR; Zhou Z
J Biol Chem; 2018 Dec; 293(51):19624-19632. PubMed ID: 30377250
[TBL] [Abstract][Full Text] [Related]
28. Fluid flow modulates electrical activity in cardiac hERG potassium channels.
Roy S; Mathew MK
J Biol Chem; 2018 Mar; 293(12):4289-4303. PubMed ID: 29305421
[TBL] [Abstract][Full Text] [Related]
29. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
Melgari D; Brack KE; Zhang C; Zhang Y; El Harchi A; Mitcheson JS; Dempsey CE; Ng GA; Hancox JC
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25911606
[TBL] [Abstract][Full Text] [Related]
30. A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome.
Gong Q; Zhang L; Moss AJ; Vincent GM; Ackerman MJ; Robinson JC; Jones MA; Tester DJ; Zhou Z
J Mol Cell Cardiol; 2008 Mar; 44(3):502-9. PubMed ID: 18272172
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
32. Phospholipid metabolite 1-palmitoyl-lysophosphatidylcholine enhances human ether-a-go-go-related gene (HERG) K(+) channel function.
Wang J; Wang H; Han H; Zhang Y; Yang B; Nattel S; Wang Z
Circulation; 2001 Nov; 104(22):2645-8. PubMed ID: 11723012
[TBL] [Abstract][Full Text] [Related]
33. N-linked glycosylation sites determine HERG channel surface membrane expression.
Petrecca K; Atanasiu R; Akhavan A; Shrier A
J Physiol; 1999 Feb; 515 ( Pt 1)(Pt 1):41-8. PubMed ID: 9925876
[TBL] [Abstract][Full Text] [Related]
34. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the human ether-a-go-go-related gene (hERG) potassium channel by Nedd4 family interacting proteins (Ndfips).
Kang Y; Guo J; Yang T; Li W; Zhang S
Biochem J; 2015 Nov; 472(1):71-82. PubMed ID: 26363003
[TBL] [Abstract][Full Text] [Related]
36. Extracellular K+ is a prerequisite for the function and plasma membrane stability of HERG channels.
Massaeli H; Guo J; Xu J; Zhang S
Circ Res; 2010 Apr; 106(6):1072-82. PubMed ID: 20133899
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a new mexiletine-derived agonist of the hERG K
Gualdani R; Cavalluzzi MM; Tadini-Buoninsegni F; Lentini G
Biophys Chem; 2017 Oct; 229():62-67. PubMed ID: 28673509
[TBL] [Abstract][Full Text] [Related]
38. Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome.
Butler A; Zhang Y; Stuart AG; Dempsey CE; Hancox JC
Physiol Rep; 2018 Sep; 6(17):e13845. PubMed ID: 30175559
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of the PAS domain of the hEAG potassium channel.
Tang X; Shao J; Qin X
Acta Crystallogr F Struct Biol Commun; 2016 Aug; 72(Pt 8):578-85. PubMed ID: 27487920
[TBL] [Abstract][Full Text] [Related]
40. Mitragynine and its potential blocking effects on specific cardiac potassium channels.
Tay YL; Teah YF; Chong YM; Jamil MFA; Kollert S; Adenan MI; Wahab HA; Döring F; Wischmeyer E; Tan ML
Toxicol Appl Pharmacol; 2016 Aug; 305():22-39. PubMed ID: 27260674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
